BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 17992279)

  • 1. Gold(I) chloride adducts of 1,3-bis(di-2-pyridylphosphino)propane: synthesis, structural studies and antitumour activity.
    Humphreys AS; Filipovska A; Berners-Price SJ; Koutsantonis GA; Skelton BW; White AH
    Dalton Trans; 2007 Nov; (43):4943-50. PubMed ID: 17992279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antitumor activity of the mixed phosphine gold species chlorotriphenylphosphine-1,3-bis(diphenylphosphino)propanegold(I).
    Caruso F; Rossi M; Tanski J; Pettinari C; Marchetti F
    J Med Chem; 2003 Apr; 46(9):1737-42. PubMed ID: 12699391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gold(III) compounds of 1,4,7-triazacyclononane showing high cytotoxicity against A-549 and HCT-116 tumor cell lines.
    Shi P; Jiang Q; Lin J; Zhao Y; Lin L; Guo Z
    J Inorg Biochem; 2006 May; 100(5-6):939-45. PubMed ID: 16472862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo antitumor activity and in vitro cytotoxic properties of bis[1,2-bis(diphenylphosphino)ethane]gold(I) chloride.
    Berners-Price SJ; Mirabelli CK; Johnson RK; Mattern MR; McCabe FL; Faucette LF; Sung CM; Mong SM; Sadler PJ; Crooke ST
    Cancer Res; 1986 Nov; 46(11):5486-93. PubMed ID: 3756897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemical behavior and in vitro activity of mixed phosphine gold(I) compounds on melanoma cell lines.
    Caruso F; Pettinari C; Paduano F; Villa R; Marchetti F; Monti E; Rossi M
    J Med Chem; 2008 Mar; 51(6):1584-91. PubMed ID: 18307291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis, characterization and assessment of the cytotoxic properties of cis and trans-[Pd(L)(2)Cl(2)] complexes involving 6-benzylamino-9-isopropylpurine derivatives.
    Trávnícek Z; Szucová L; Popa I
    J Inorg Biochem; 2007 Mar; 101(3):477-92. PubMed ID: 17208304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chloro half-sandwich osmium(II) complexes: influence of chelated N,N-ligands on hydrolysis, guanine binding, and cytotoxicity.
    Peacock AF; Habtemariam A; Moggach SA; Prescimone A; Parsons S; Sadler PJ
    Inorg Chem; 2007 May; 46(10):4049-59. PubMed ID: 17441712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A gold(I) phosphine complex selectively induces apoptosis in breast cancer cells: implications for anticancer therapeutics targeted to mitochondria.
    Rackham O; Nichols SJ; Leedman PJ; Berners-Price SJ; Filipovska A
    Biochem Pharmacol; 2007 Oct; 74(7):992-1002. PubMed ID: 17697672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toward a novel metal-based chemotherapy against tropical diseases. 7. Synthesis and in vitro antimalarial activity of new gold-chloroquine complexes.
    Navarro M; Vásquez F; Sánchez-Delgado RA; Pérez H; Sinou V; Schrével J
    J Med Chem; 2004 Oct; 47(21):5204-9. PubMed ID: 15456263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The synthesis, chemical and biological properties of dichlorido(azpy)gold(III) chloride (azpy=2-(phenylazo)pyridine) and the gold-induced conversion of the azpy ligand to the chloride of the novel tricyclic pyrido[2,1-c][1,2,4]benzotriazin-11-ium cation.
    Garza-Ortiz A; den Dulk H; Brouwer J; Kooijman H; Spek AL; Reedijk J
    J Inorg Biochem; 2007 Nov; 101(11-12):1922-30. PubMed ID: 17637477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complexes of dichloro[2-(dimethylaminomethyl)phenyl-C1,N]gold(III), [Au(damp-C1,N)Cl2], with formylferrocene thiosemicarbazones: synthesis, structure and cytotoxicity.
    Casas JS; Castaño MV; Cifuentes MC; García-Monteagudo JC; Sánchez A; Sordo J; Abram U
    J Inorg Biochem; 2004 Jun; 98(6):1009-16. PubMed ID: 15149809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anticancer cyclometalated [Au(III)m(C(wedge)N(wedge)C)mL]n+ compounds: Synthesis and cytotoxic properties.
    Li CK; Sun RW; Kui SC; Zhu N; Che CM
    Chemistry; 2006 Jul; 12(20):5253-66. PubMed ID: 16642532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis, structure and cytotoxicity of triphenylphosphinegold(I) sulfanylpropenoates.
    Barreiro E; Casas JS; Couce MD; Sánchez A; Sánchez-Gonzalez A; Sordo J; Varela JM; Vázquez López EM
    J Inorg Biochem; 2008 Feb; 102(2):184-92. PubMed ID: 17870173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation of AuPd22/Au2Pd21 analogues of the high-nuclearity Pd23(CO)20(PEt3)10 cluster containing 19-atom centered hexacapped-cuboctahedral (nu 2-octahedral) metal fragment: structural-to-synthesis approach concerning formation of Au2Pd21(CO)20(PEt3)10.
    Tran NT; Powell DR; Dahl LF
    Dalton Trans; 2004 Jan; (2):209-16. PubMed ID: 15356714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis, crystal structures and cytotoxicities of some transition metal complexes with N-[2-{(pyridin-2-ylmethylidene)amino}ethyl]acetamide.
    Zhao X; Lee PP; Yan YK; Chu CK
    J Inorg Biochem; 2007 Feb; 101(2):321-8. PubMed ID: 17140666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mononuclear, dinuclear, and hexanuclear goldI complexes with (aza-15-crown-5)dithiocarbamate.
    Arias J; Bardají M; Espinet P
    Inorg Chem; 2008 Mar; 47(5):1597-606. PubMed ID: 18237120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Three- and four-coordinate gold(I) complexes of 3,6-bis(diphenylphosphino)pyridazine: monomers, polymers, and a metallocryptand cage.
    Catalano VJ; Malwitz MA; Horner SJ; Vasquez J
    Inorg Chem; 2003 Mar; 42(6):2141-8. PubMed ID: 12639153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and anticancer activity of lipophilic platinum(II) complexes of 3,5-diisopropylsalicylate.
    Yu Y; Lou LG; Liu WP; Zhu HJ; Ye QS; Chen XZ; Gao WG; Hou SQ
    Eur J Med Chem; 2008 Jul; 43(7):1438-43. PubMed ID: 17959272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of lipophilicity in determining cellular uptake and antitumour activity of gold phosphine complexes.
    McKeage MJ; Berners-Price SJ; Galettis P; Bowen RJ; Brouwer W; Ding L; Zhuang L; Baguley BC
    Cancer Chemother Pharmacol; 2000; 46(5):343-50. PubMed ID: 11127937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytotoxic studies of substituted titanocene and ansa-titanocene anticancer drugs.
    Gómez-Ruiz S; Kaluderović GN; Prashar S; Polo-Cerón D; Fajardo M; Zizak Z; Sabo TJ; Juranić ZD
    J Inorg Biochem; 2008 Aug; 102(8):1558-70. PubMed ID: 18353439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.